Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis.

Maria Pia SormaniNicola De RossiIrene SchiavettiLuca CarmiscianoCinzia CordioliLucia MoiolaMarta RadaelliPaolo ImmovilliMarco CapobiancoMaria TrojanoPaola ZaratinGioacchino TedeschiGiancarlo ComiMario A BattagliaFrancesco PattiMarco Salvettinull null

Published in: Annals of neurology (2021)

This study showed an acceptable level of safety of therapies with a broad array of mechanisms of action. However, some specific elements of risk emerged. These will need to be considered while the COVID-19 pandemic persists. ANN NEUROL 2021;89:780-789.

Keyphrases

multiple sclerosis
coronavirus disease
high throughput
high resolution
white matter
sars cov
neural network
single cell